1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => FreeToRead
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)


  
    



























































































































    Association between CYP2C19 Polymorphisms and Outcomes in Cerebral Endovascular Therapy | American Journal of Neuroradiology  
    



















    































    
  
  




    
    

  

      


    

      

  
  
  

    

  

    

  

                
    

      

  

    

  
      
  
  

    


Advertisement



  



  


  
  



  



    

  


  


  


  
  
  
  
  
  

  	      


    
      

    
  
    
        
    

  

    
                        

  

                
    

      

	  

		
		

			

			  

  
      
  
  

    

  
  
      
Research ArticleINTERVENTIONAL

  
      

  
      
Association between CYP2C19 Polymorphisms and Outcomes in Cerebral Endovascular Therapy
  
    	
M. Lin, M. Todaro, J. Chan, L. Churilov, W.S. Zhu, S. Ramdave, P.J. Mitchell, R.J. Dowling, P. Kwan and B. Yan

  
    	
American Journal of Neuroradiology January 2016,  37 (1) 108-113; DOI: https://doi.org/10.3174/ajnr.A4481 

  
  
  



  


  
  



			

		

	
	
 	
	  
  

		
		

			

			  

  
      
  
  

    
  


  
  



  
      
  
  

    

  

    

  
      
  
  

    
References
  1. 1.↵
    1. 

    2. Molyneux  A, 
    3. Kerr  R, 
    4. Stratton  I, et al
    ; International Subarachnoid Aneurysm Trial (ISAT) Collaborative Group. International Subarachnoid Aneurysm Trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised trial. Lancet 2002;360:1267–74 doi:10.1016/S0140-6736(02)11314-6 pmid:12414200
    CrossRefPubMedWeb of Science
  2. 2.↵
    1. 

    2. Lee  DH, 
    3. Kim  HS, 
    4. Kim  SM, et al
    . Change of platelet reactivity to antiplatelet therapy after stenting procedure for cerebral artery stenosis: VerifyNow antiplatelet assay before and after stenting. Neurointervention 2012;7:23–26 doi:10.5469/neuroint.2012.7.1.23 pmid:22454781
    CrossRefPubMed
  3. 3.↵
    1. 

    2. Zhang  QY, 
    3. Li  Y, 
    4. Guan  SY, et al
    . Incidence and predictors of definite stent thrombosis after coronary stent implantation. Chin Med J (Engl) 2012;125:1547–51 pmid:22800819
    PubMed
  4. 4.↵
    1. 

    2. Yamada  NK, 
    3. Cross  DT  3rd., 
    4. Pilgram  TK, et al
    . Effect of antiplatelet therapy on thromboembolic complications of elective coil embolization of cerebral aneurysms. AJNR Am J Neuroradiol 2007;28:1778–82 doi:10.3174/ajnr.A0641 pmid:17885244
    Abstract/FREE Full Text
  5. 5.↵
    1. 

    2. Kang  HS, 
    3. Han  MH, 
    4. Kwon  BJ, et al
    . Is clopidogrel premedication useful to reduce thromboembolic events during coil embolization for unruptured intracranial aneurysms? Neurosurgery 2010;67:1371–76; discussion 1376 doi:10.1227/NEU.0b013e3181efe3ef pmid:20871459
    CrossRefPubMedWeb of Science
  6. 6.↵
    1. 

    2. Kazui  M, 
    3. Nishiya  Y, 
    4. Ishizuka  T, et al
    . Identification of the human cytochrome P450 enzymes involved in the two oxidative steps in the bioactivation of clopidogrel to its pharmacologically active metabolite. Drug Metab Dispos 2010;38:92–99 doi:10.1124/dmd.109.029132 pmid:19812348
    Abstract/FREE Full Text
  7. 7.↵
    1. 

    2. Grau  AJ, 
    3. Reiners  S, 
    4. Lichy  C, et al
    . Platelet function under aspirin, clopidogrel, and both after ischemic stroke: a case-crossover study. Stroke 2003;34:849–54 doi:10.1161/01.STR.0000064326.65899.AC pmid:12637702
    Abstract/FREE Full Text
  8. 8.↵
    1. 

    2. Collet  JP, 
    3. Hulot  JS, 
    4. Pena  A, et al
    . Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: a cohort study. Lancet 2009;373:309–17 doi:10.1016/S0140-6736(08)61845-0 pmid:19108880
    CrossRefPubMedWeb of Science
  9. 9.↵
    1. 

    2. Brandt  JT, 
    3. Close  SL, 
    4. Iturria  SJ, et al
    . Common polymorphisms of CYP2C19 and CYP2C9 affect the pharmacokinetic and pharmacodynamic response to clopidogrel but not prasugrel. J Thromb Haemost 2007;5:2429–36 doi:10.1111/j.1538-7836.2007.02775.x pmid:17900275
    CrossRefPubMedWeb of Science
  10. 10.↵
    1. 

    2. Rho  GJ, 
    3. Shin  WR, 
    4. Kong  TS, et al
    . Significance of clopidogrel resistance related to the stent-assisted angioplasty in patients with atherosclerotic cerebrovascular disease. J Korean Neurosurg Soc 2011;50:40–44 doi:10.3340/jkns.2011.50.1.40 pmid:21892403
    CrossRefPubMed
  11. 11.↵
    1. 

    2. Pandya  DJ, 
    3. Fitzsimmons  BF, 
    4. Wolfe  TJ, et al
    . Measurement of antiplatelet inhibition during neurointerventional procedures: the effect of antithrombotic duration and loading dose. J Neuroimaging 2010;20:64–69 doi:10.1111/j.1552-6569.2008.00322.x pmid:19018951
    CrossRefPubMedWeb of Science
  12. 12.↵
    1. 

    2. Shuldiner  AR, 
    3. O'Connell  JR, 
    4. Bliden  KP, et al
    . Association of cytochrome P450 2C19 genotype with the antiplatelet effect and clinical efficacy of clopidogrel therapy. JAMA 2009;302:849–57 doi:10.1001/jama.2009.1232 pmid:19706858
    CrossRefPubMedWeb of Science
  13. 13.↵
    1. 

    2. Goh  C, 
    3. Churilov  L, 
    4. Mitchell  P, et al
    . Clopidogrel hyper-response and bleeding risk in neurointerventional procedures. AJNR Am J Neuroradiol 2013;34:721–26 doi:10.3174/ajnr.A3418 pmid:23275598
    Abstract/FREE Full Text
  14. 14.↵
    1. 

    2. Sibbing  D, 
    3. Koch  W, 
    4. Gebhard  D, et al
    . Cytochrome 2C19*17 allelic variant, platelet aggregation, bleeding events, and stent thrombosis in clopidogrel-treated patients with coronary stent placement. Circulation 2010;121:512–18 doi:10.1161/CIRCULATIONAHA.109.885194 pmid:20083681
    Abstract/FREE Full Text
  15. 15.↵
    1. 

    2. Cresci  S, 
    3. Depta  JP, 
    4. Lenzini  PA, et al
    . Cytochrome P450 gene variants, race, and mortality among clopidogrel-treated patients after acute myocardial infarction. Circ Cardiovasc Genet 2014;7:277–86 doi:10.1161/CIRCGENETICS.113.000303 pmid:24762860
    Abstract/FREE Full Text
  16. 16.↵
    1. 

    2. Dias  V, 
    3. Cabral  S, 
    4. Gomes  C, et al
    . Intramyocardial dissecting haematoma: a rare complication of acute myocardial infarction. Eur J Echocardiogr 2009;10:585–87 doi:10.1093/ejechocard/jep027 pmid:19339261
    Abstract/FREE Full Text
  17. 17.↵
    1. 

    2. Darweesh  SK, 
    3. Leening  MJ, 
    4. Akoudad  S, et al
    . Clopidogrel use is associated with an increased prevalence of cerebral microbleeds in a stroke-free population: the Rotterdam study. J Am Heart Assoc 2013;2:e000359 doi:10.1161/JAHA.113.000359 pmid:24072532
    Abstract/FREE Full Text
  18. 18.↵
    1. 

    2. Godino  C, 
    3. Mendolicchio  L, 
    4. Figini  F, et al
    . Comparison of VerifyNow-P2Y12 test and Flow Cytometry for monitoring individual platelet response to clopidogrel: what is the cut-off value for identifying patients who are low responders to clopidogrel therapy? Thromb J 2009;7:4 doi:10.1186/1477-9560-7-4 pmid:19419580
    CrossRefPubMed
  19. 19.↵
    1. 

    2. De Morais  SM, 
    3. Wilkinson  GR, 
    4. Blaisdell  J, et al
    . Identification of a new genetic defect responsible for the polymorphism of (S)-mephenytoin metabolism in Japanese. Mol Pharmacol 1994;46:594–98 pmid:7969038
    Abstract
  20. 20.↵
    1. 

    2. Rudberg  I, 
    3. Mohebi  B, 
    4. Hermann  M, et al
    . Impact of the ultrarapid CYP2C19*17 allele on serum concentration of escitalopram in psychiatric patients. Clin Pharmacol Ther 2008;83:322–27 doi:10.1038/sj.clpt.6100291 pmid:17625515
    CrossRefPubMedWeb of Science
  21. 21.↵
    1. 

    2. Huang  Y, 
    3. Guo  JW
    ; Project Group for Demonstration Study of Syndrome Differentiation Protocol and Effect Evaluation of Acute Ischemic Stroke. Outcome and safety assessment of an herbal medicine treatment protocol for yin pattern of acute ischemic stroke. Zhong Xi Yi Jie He Xue Bao 2010;8:417–26 doi:10.3736/jcim20100504 pmid:20456839
    CrossRefPubMed
  22. 22.↵
    1. 

    2. Geisler  T, 
    3. Schaeffeler  E, 
    4. Dippon  J, et al
    . CYP2C19 and nongenetic factors predict poor responsiveness to clopidogrel loading dose after coronary stent implantation. Pharmacogenomics 2008;9:1251–59 doi:10.2217/14622416.9.9.1251 pmid:18781853
    CrossRefPubMedWeb of Science
  23. 23.↵
    1. 

    2. Lee  JB, 
    3. Lee  KA, 
    4. Lee  KY
    . Cytochrome P450 2C19 polymorphism is associated with reduced clopidogrel response in cerebrovascular disease. Yonsei Med J 2011;52:734–38 doi:10.3349/ymj.2011.52.5.734 pmid:21786436
    CrossRefPubMed
  24. 24.↵
    1. 

    2. Hulot  JS, 
    3. Bura  A, 
    4. Villard  E, et al
    . Cytochrome P450 2C19 loss-of-function polymorphism is a major determinant of clopidogrel responsiveness in healthy subjects. Blood 2006;108:2244–47 doi:10.1182/blood-2006-04-013052 pmid:16772608
    Abstract/FREE Full Text
  25. 25.↵
    1. 

    2. Harmsze  AM, 
    3. van Werkum  JW, 
    4. Ten Berg  JM, et al
    . CYP2C19*2 and CYP2C9*3 alleles are associated with stent thrombosis: a case-control study. Eur Heart J 2010;31:3046–53 doi:10.1093/eurheartj/ehq321 pmid:20833683
    Abstract/FREE Full Text
  26. 26.↵
    1. 

    2. Ryu  DS, 
    3. Hong  CK, 
    4. Sim  YS, et al
    . Anti-platelet drug resistance in the prediction of thromboembolic complications after neurointervention. J Korean Neurosurg Soc 2010;48:319–24 doi:10.3340/jkns.2010.48.4.319 pmid:21113358
    CrossRefPubMed
  27. 27.↵
    1. 

    2. Prabhakaran  S, 
    3. Wells  KR, 
    4. Lee  VH, et al
    . Prevalence and risk factors for aspirin and clopidogrel resistance in cerebrovascular stenting. AJNR Am J Neuroradiol 2008;29:281–85 doi:10.3174/ajnr.A0818 pmid:17989373
    Abstract/FREE Full Text
  28. 28.↵
    1. 

    2. Nordeen  JD, 
    3. Patel  AV, 
    4. Darracott  RM, et al
    . Clopidogrel resistance by P2Y12 platelet function testing in patients undergoing neuroendovascular procedures: incidence of ischemic and hemorrhagic complications. J Vasc Interv Neurol 2013;6:26–34 pmid:23826440
    PubMed
  


  
  



  




  


  
  



  
      
  
  

    
  


  
  



  
      
  
  

     Back to top  


  
  



			

		

		
		

			

			  

  
        
In this issue

    
  
  

    
  


  
  



  
      
  
  

    

  

    

  
      
  
  

    


Advertisement



  



  


  
  



  



  


  
  



  
      
  
  

    

	  
  

		

          

            

  
      
  
  

     Print  


  
  



  
      
  
  

     Download PDF  


  
  



  
      
  
  

    
 Email Article
  


  
  



  
      
  
  

    
 Citation Tools
  


  
  



          

        

        
        

          

            



  
      
  
  

    

  

    

  
      
  
  

    

  
  
  
  
      
Association between CYP2C19 Polymorphisms and Outcomes in Cerebral Endovascular Therapy
  
    	
M. Lin, M. Todaro, J. Chan, L. Churilov, W.S. Zhu, S. Ramdave, P.J. Mitchell, R.J. Dowling, P. Kwan, B. Yan

  
    	
American Journal of Neuroradiology Jan 2016, 37 (1) 108-113; DOI: 10.3174/ajnr.A4481 

  
  
  



  


  
  



  
      
  
  

    

  
    
  
  
    
  
  
    
  


  


  
  



  
      
  
  

    
del.icio.us logo Twitter logo Facebook logo Mendeley logo
  


  
  



  



  


  
  



  
      
  
  

    
  


  
  



          

        

	
 	
	
	


  


  
  



  
      
  
  

    
              Purchase  


  
  



  
        
Jump to section

    
  
  

    
  


  
  



  
      
  
  

    
  


  
  



			

		

	
	
 	
	
	


    

  



  

                
    

      

  

    

  
      
  
  

    


Advertisement